Allergic Conjunctivitis Market, By Drug Class (Antihistamines & Mast Cell Stabilizers, Corticosteroids, and Others), By Disease Type (Mild Allergic Conjunctivitis and Severe Allergic Conjunctivitis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Published In : Aug 2021

Code : CMI4570

Pages :188

Formats :

Excel and PDF

Industry : Pharmaceutical

Market Challenges And Opportunities

Global Allergic Conjunctivitis Market: Restraint

The major factors that hinder growth of the global allergic conjunctivitis market include the lack of awareness of ocular allergies and its adverse reaction towards medication.

Lack of awareness of ocular allergies
Adverse reaction towards allergic conjunctivitis medications

Global Allergic Conjunctivitis Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus (COVID-19) has resulted in more than 198 million infected individuals worldwide as of August 2, 2021.

COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of drugs from one place to another.

Furthermore, players operating in the global allergic conjunctivitis market are facing major challenges on various fronts due to the COVID-19 pandemic. Major challenges include the supply of raw materials required for manufacturing drug formulations due to irregularities in transportation. Moreover, distributors are experiencing irregular demand for products from the retailers due to an increase in the number of patients suffering from COVID-19 and other life threatening disorders.